480
Views
17
CrossRef citations to date
0
Altmetric
Psoriasis

Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population

, , , &
Pages 25-33 | Received 19 Dec 2011, Accepted 13 Jan 2012, Published online: 05 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Andrew Blauvelt, Nianwen Shi, Russel Burge, William N Malatestinic, Chen-Yen Lin, Carolyn R Lew, Nicole M Zimmerman, Orin M Goldblum, Baojin Zhu & Mwangi J Murage. (2020) Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab. Patient Preference and Adherence 14, pages 517-527.
Read now
Sara Higa, Beth Devine, Vaishali Patel, Sarah Baradaran, Degang Wang & Aasthaa Bansal. (2019) Psoriasis treatment patterns: a retrospective claims study. Current Medical Research and Opinion 35:10, pages 1727-1733.
Read now
Mwangi J Murage, Vanita Tongbram, Steven R Feldman, William N Malatestinic, Cynthia J Larmore, Talia M Muram, Russel T Burge, Charles Bay, Nicole Johnson, Sarah Clifford & Andre B Araujo. (2018) Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review. Patient Preference and Adherence 12, pages 1483-1503.
Read now
Javaria Mona Khalid, Kathleen M Fox, Gary Globe, Andrew Maguire & Dina Chau. (2014) Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England. Journal of Dermatological Treatment 25:1, pages 67-72.
Read now
Machaon Bonafede, Barbara H. Johnson, Kathleen M. Fox, Crystal Watson & Shravanthi R. Gandra. (2013) Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting. Journal of Dermatological Treatment 24:5, pages 369-373.
Read now

Articles from other publishers (11)

Eugenia Piragine, Davide Petri, Alma Martelli, Agata Janowska, Valentina Dini, Marco Romanelli, Vincenzo Calderone & Ersilia Lucenteforte. (2022) Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis. Journal of Clinical Medicine 11:6, pages 1506.
Crossref
Shekhar Neema, Disha Dabbas, S. Radhakrishnan & Arun Kumar Yadav. (2021) Pattern of use of biologics in psoriasis among Indian dermatologists – A cross sectional survey. Indian Journal of Dermatology, Venereology and Leprology 88, pages 515-518.
Crossref
Nikos Maniadakis, Emese Toth, Michael Schiff, Xuan Wang, Maria Nassim, Boglarka Szegvari, Irina Mountian & Jeffrey R. Curtis. (2018) A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences. Advances in Therapy 35:9, pages 1333-1355.
Crossref
J. AlbrechtS. Gerdes. (2017) Switching expensive drugs with frequently diminishing value. British Journal of Dermatology 177:2, pages 338-339.
Crossref
I.Y.K. Iskandar, D.M. Ashcroft, R.B. Warren, I. Evans, K. McElhone, C.M. Owen, A.D. Burden, C.H. Smith, N.J. Reynolds & C.E.M. Griffiths. (2017) Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). British Journal of Dermatology 176:5, pages 1297-1307.
Crossref
April W. Armstrong, J. Will Koning, Simon Rowse, Huaming Tan, Carla Mamolo & Mandeep Kaur. (2017) Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States. Clinical Drug Investigation 37:5, pages 493-501.
Crossref
Tao Gu, Neel Shah, Gaurav Deshpande, Derek H. Tang & Debra F. Eisenberg. (2016) Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study. Drugs - Real World Outcomes 3:4, pages 369-381.
Crossref
Eleni Vangeli, Savita Bakhshi, Anna Baker, Abigail Fisher, Delaney Bucknor, Ulrich Mrowietz, Andrew J. K. Östör, Laurent Peyrin-Biroulet, Ana P. Lacerda & John Weinman. (2015) A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases. Advances in Therapy 32:11, pages 983-1028.
Crossref
Kathryn L. Anderson & Steven R. Feldman. (2015) Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis. Journal of Cutaneous Medicine and Surgery 19:4, pages 361-366.
Crossref
A. Svedbom, J. Dalén, C. Mamolo, J.C. Cappelleri, I.F. Petersson & M. Ståhle. (2014) Treatment patterns with topicals, traditional systemics and biologics in psoriasis – a S wedish database analysis . Journal of the European Academy of Dermatology and Venereology 29:2, pages 215-223.
Crossref
Sarah Q. ToKevin C. KnowerColin D. Clyne. (2013) Origins and Actions of Tumor Necrosis Factor α in Postmenopausal Breast Cancer. Journal of Interferon & Cytokine Research 33:7, pages 335-345.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.